Risk factors predicting progression of diabetic retinopathy over six years in 1579 NIDDM patients

Risk factors predicting progression of diabetic retinopathy over six years in 1579 NIDDM patients

Podrobná bibliografie
Hlavní autoři:	Stratton, I, Kohner, E, Matthews, DR, Holman, R, Aldington, S, Turner, R
Médium:	Journal article
Vydáno:	1996

Podobné jednotky

PROGRESSION OF DIABETIC-RETINOPATHY OVER 6 YEARS IN PATIENTS STUDIED IN THE UK PROSPECTIVE DIABETES STUDY
Autor: Aldington, S, a další
Vydáno: (1994)

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
Autor: Stratton, I, a další
Vydáno: (2001)

Nine-year status of diabetic retinopathy and photocoagulation in the UK prospective diabetes study.
Autor: Aldington, S, a další
Vydáno: (1996)

PROGRESSION OF DIABETIC-RETINOPATHY IN TYPE-2 DIABETIC-PATIENTS IN THE UK PROSPECTIVE DIABETES STUDY
Autor: Stratton, I, a další
Vydáno: (1993)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
Autor: Kohner, E, a další
Vydáno: (2001)

RETINOPATHY IN THE UKPDS TRIAL MICRO-ANEURYSM COUNTS AND THE RISKS OF PROGRESSION OVER 3-YEARS AND 6-YEARS
Autor: Matthews, D, a další
Vydáno: (1995)

Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
Autor: Matthews, DR, a další
Vydáno: (2004)

Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group.
Autor: Kohner, E, a další
Vydáno: (1999)

United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors.
Autor: Kohner, E, a další
Vydáno: (1998)

PREVALENCE OF RETINOPATHY AT DIAGNOSIS OF TYPE-II DIABETES IN THE UK PROSPECTIVE DIABETES STUDY
Autor: Kohner, E, a další
Vydáno: (1993)

PREVALENCE OF DIABETIC-RETINOPATHY AT DIAGNOSIS OF NON-INSULIN-DEPENDENT DIABETES IN THE UNITED-KINGDOM PROSPECTIVE DIABETES STUDY
Autor: Kohner, E, a další
Vydáno: (1993)

PREVALENCE OF DIABETIC-RETINOPATHY AT DIAGNOSIS OF NON-INSULIN-DEPENDENT DIABETES IN 2964 WHITE CAUCASIAN SUBJECTS AND ASSOCIATION WITH HYPERTENSION, HYPERGLYCEMIA AND IMPAIRED BETA-CELL FUNCTION
Autor: Stratton, I, a další
Vydáno: (1995)

Effects of ethnicity on metabolic control during the first six years of NIDDM
Autor: Davis, T, a další
Vydáno: (1997)

Evaluating risk of progression to photocoagulation by retinal photography or direct ophthalmoscopy.
Autor: Stratton, I, a další
Vydáno: (1997)

U.K. Prospective Diabetes Study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM.
Autor: Davis, T, a další
Vydáno: (1997)

Treatment of NIDDM - Progressive requirement for polypharmacy to attain glycaemic goals
Autor: Cull, C, a další
Vydáno: (1997)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
Autor: Matthews, DR, a další
Vydáno: (1998)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
Autor: Matthews, DR, a další
Vydáno: (1998)

Glycaemic improvement over one year in a double-blind trial of acarbose in 1,946 NIDDM patients
Autor: Holman, R, a další
Vydáno: (1996)

UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM.
Autor: Keavney, B, a další
Vydáno: (1995)

Risk factors for presence of hard exudates at diagnosis of Type 2 diabetes and after 6 years.
Autor: Stratton, J, a další
Vydáno: (2003)

Insulin use in NIDDM. Rationale based on pathophysiology of disease.
Autor: Turner, R, a další
Vydáno: (1990)

No glycemic benefit from guar administration in NIDDM.
Autor: Holman, R, a další
Vydáno: (1987)

CIGMA as a tool in the study of NIDDM.
Autor: Turner, R, a další
Vydáno: (1988)

UK PROSPECTIVE DIABETES STUDY 16 - OVERVIEW OF 6 YEARS THERAPY OF TYPE-II DIABETES - A PROGRESSIVE DISEASE
Autor: Turner, R, a další
Vydáno: (1995)

The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010.
Autor: Scanlon, P, a další
Vydáno: (2013)

Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy.
Autor: Scanlon, P, a další
Vydáno: (2014)

Coronary heart disease and risk factors in NIDDM--experience from the United Kingdom Prospective Diabetes Study.
Autor: Turner, R, a další
Vydáno: (1997)

Epidemiological issues in diabetic retinopathy.
Autor: Scanlon, P, a další
Vydáno: (2013)

Pathogenesis of NIDDM--a disease of deficient insulin secretion.
Autor: Turner, R, a další
Vydáno: (1988)

Sulphonylurea therapy over six years does not delay progression to diabetes
Autor: Herlihy, O, a další
Vydáno: (2000)

U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM.
Autor: Dudley, C, a další
Vydáno: (1995)

A Practical Manual of Diabetic Retinopathy Management
Autor: Scanlon, P, a další
Vydáno: (2009)

Personalised risk estimation for progression to sight-threatening diabetic retinopathy: how much does clinical information add to screening data?
Autor: Stratton, I, a další
Vydáno: (2014)

Post-prandial amylin concentrations are increased by sulphonylurea, but unchanged by basal insulin, in NIDDM
Autor: Rachman, J, a další
Vydáno: (1996)

Segregation analysis of NIDDM in Caucasian families.
Autor: Cook, J, a další
Vydáno: (1994)

STUDY DESIGN OF THE UK PROSPECTIVE DIABETES STUDY AND PROGRESS OF EYE DATA
Autor: Stratton, I, a další
Vydáno: (1993)

Reinforced healthy living advice over six years does not delay progression to diabetes
Autor: Dyson, P, a další
Vydáno: (2000)

Thyroid dysfunction and its relation with diabetes mellitus (NIDDM)
Autor: H.R.Bazrafshan (M.D), a další
Vydáno: (2000-03-01)

Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
Autor: Rachman, J, a další
Vydáno: (1998)